New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 4, 2014
09:13 EDTMYL, OPTT, ALGN, MRCY, BA, HALO, KMX, MU, SNX, PBPB, GMEOn The Fly: Pre-market Movers
HIGHER: Mylan (MYL), up 6.8% after report of desire to buy Swedish rival Meda, which confirmed it had been in talks with Mylan but rejected the company's takeover offer. Shares of Mylan were also upgraded to Buy this morning at Citigroup... Mercury Systems (MRCY), up 8.8% after Reuters said Boeing (BA) is considering a takeover bid of the supplier..Micron (MU), up 3% after reporting earnings and revenue that topped expectations... Align (ALGN), up 6% after winning patent case against ClearCorrect... GameStop (GME), up 2.8% following upgrade at BofA Merrill Lynch... Potbelly (PBPB), up 4.6% after upgrade at William Blair.... SYNNEX (SNX), up 18.5% after earnings report. LOWER: CarMax (KMX), down 3.3% after reporting earnings and revenue that fell below expectations... Halozyme (HALO), down 33% after announcing temporary halt of Phase 2 trial enrollment for PEGPH20... Ocean Power (OPTT), down 15% after 3.8M share Spot Secondary priced at $3.10.
News For MYL;MU;MRCY;GME;KMX;ALGN;PBPB;HALO;OPTT;SNX;BA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
December 10, 2014
09:36 EDTKMXActive equity options trading
Subscribe for More Information
08:52 EDTBABoeing delivery of first 787 to American delayed again, Dallas News reports
Subscribe for More Information
08:15 EDTBAWoodward signs supply agreement with Boeing
Subscribe for More Information
07:38 EDTMYLMylan launches generic version of Pfizer's Celebrex capsules
Mylan (MYL) announced the U.S. launch of its Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg, one of the first available generic versions of Pfizer's (PFE) Celebrex Capsules, indicated for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and for the management of acute pain in adults. Celecoxib Capsules had U.S. sales of approximately $2.5B for the 12 months ending September 30, 2014.
06:47 EDTBABoeing says China planes deliveries to hit record in 2014, China Daily says
Subscribe for More Information
06:27 EDTBACongress authorizes $1.46B for Boeing attack jets, Reuters says
Subscribe for More Information
06:08 EDTBABoeing cutting over 560 employees in Southern California, LA Times reports
According to documents filed in California, Boeing is planning to lay off 253 people at its Long Beach facilities, 154 in Huntington Beach and 154 employees in El Segundo, the LA Times reports. The layoffs will occur this month and in early 2015. Reference Link
December 9, 2014
12:38 EDTBABoeing 747 production rate cut not surprising, says Wells Fargo
Subscribe for More Information
12:34 EDTBABoeing to cut 747-8 production to 1.3 from 1.5 per month, WSJ reports
Boeing confirmed plans to lower 747-8 jetliner monthly production to 1.3 per month from 1.5, which will reduce annual deliveries to 16 from 18, in September of next year, reported The Wall Street Journal. Boeing said the cut enables it to "continue to run a healthy business, the Journal quoted the company as stating. Reference Link
06:25 EDTMUMicron attempt to renegotiate supply agreement with Inotera, DigiTimes says
Subscribe for More Information
06:22 EDTBABoeing sees strong demand for commercial airplanes in 2015
Subscribe for More Information
December 8, 2014
11:30 EDTMYLLeerink generics pharmaceutical analyst holds analyst/industry conference call
Subscribe for More Information
07:36 EDTMUMicron December volatility of 31 at low end of historic range
Subscribe for More Information
07:32 EDTSNXRaymond James to hold a conference
Subscribe for More Information
06:42 EDTPBPBPotbelly coverage resumed with a Neutral at Goldman
Subscribe for More Information
05:43 EDTBABoeing Business Jets, Comlux announces order for two BBJ MAX 8s
Subscribe for More Information
December 5, 2014
13:55 EDTMUMicron CEO said to be upbeat on DRAM pricing, CNBC's Lee reports
Subscribe for More Information
10:05 EDTMYLBristol-Myers jumps 2% amid talk of potential Pfizer bid
Shares of Bristol-Myers (BMY) are up in early trading amid chatter of a potential takeover bid from Pfizer (PFE). The stock is up $1.26 to $60.15. Bristol's market capitalization stands around $99B, less than twice that of Pfizer's $200B. A Jefferies analyst last week called Mylan (MYL) the most likely takeover target for Pfizer. Pfizer is "highly motivated" to buy a foreign company using its overseas cash and Mylan looks like the most likely target, Jefferies analyst Jeffrey Holford wrote.
06:21 EDTMUDRAMeXchange: DRAM spot prices hit 7-month low, DigiTimes says
Subscribe for More Information
06:00 EDTMUMicron management to meet with Wedbush
Meeting to be held in New York on December 8 hosted by Wedbush.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use